Neurology

Trial shows candesartan cuts migraine days and is well tolerated. Read more to learn about this promising prevention therapy.

Study links sugary drink intake and depression to gut microbiome changes, especially in women, suggesting new prevention strategies.

Skin-to-skin contact in hospital helps very preterm infants develop stronger brain pathways for stress and emotions.

Adaptive brain stimulation proves safe and effective for Parkinson, reducing side effects while maintaining long-term symptom control.

Large-scale observational and genetic analyses reveal that alcohol consumption is associated with higher dementia risk. Genetic evidence contradicts protective effects of light drinking.

A Phase I/II trial of AMT-130 gene therapy slowed Huntington’s disease progression by 75% over 36 months, showing biomarker and functional benefits.

Dementia prevention must start in childhood, with new evidence linking lifelong social adversity to brain decline and disease risk.

Half of critically ill encephalitis patients face poor outcomes within months, but recovery varies by cause. Keep reading to learn more.